- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
VITIS GmbH
VITIS GmbH is listed as a consultant research supplier in the Scientist.com network, with 1 site in 1 country.
View VITIS GmbH on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
1
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Consultant
Clinical Consulting
- Study Budgeting Consulting Request for Consulting Services
Data Science/Bioinformatics
- FAIR data strategy consulting FAIR data strategy consulting involves guiding organizations to adopt data management practices that ensure their data is Findable, Accessible, Interoperable, and Reusable, thereby enhancing data usability and value.
- RWE/HEOR Data Management A process that includes acquiring, validating, storing, protecting, and processing required data to ensure the accessibility, reliability, and timeliness of the data.
- RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects
- RWE/HEOR Market Analysis A process to understand how a drug is performing in the market and possible opportunities in the market
HEOR
- Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
- Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
- HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
Market Access
- Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
- Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
- Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
- Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
- Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
- Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
Show all 7 in Market Access
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
Show all 35 services
Medical Communications
- HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
- Medical Academy Training Developing structured, curriculum-based training programs for internal medical affairs teams, focusing on scientific, therapeutic, and compliance knowledge mastery.
- Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
Old Category HEOR, RWE, Market Access
- RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
Primary Market Research
- Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
Real World Evidence & Data
- Claims Data & Database Analysis Analysis of care cost and quality.
- Claims Data - Billing Includes patient demographics, insurance status, geographical location, among others.
- Claims Data - Pharmacy Includes medications, prescription orders, payment submissions, patient adherence, among others.
- Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
- Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
- Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
Show all 13 in Real World Evidence & Data
- Quantitative or Qualitative Research Either to understand concepts, thoughts, or experiences with qualitative research or to quantify the problem by generating numerical data or data that can be transformed into usable statistics with quantitative research.
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
- Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
- Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
- RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
- RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
- RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
- Website
- www.vitis-healthcare.com
Where it operates
Sites by country, with the cities in each.
-
Germany 1 site
Work with VITIS GmbH on Scientist.com
For prices, more details, or to contact VITIS GmbH, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.